Novartis’ tone-deaf response to Michael Cohen: troubling, but not surprising
Novartis' contract with Michael Cohen, President Trump's lawyer, isn't its first questionable deal.
When Donald Trump’s lawyer, Michael Cohen, approached Novartis early last year to provide access to the new Trump administration, the company’s response was tone-deaf. But it was hardly a surprise.
The personal lawyer and “fixer” for the president came knocking as big drug makers were anxious about the future, since candidate Trump had for through-the-roof prices. So former Novartis chief executive Joe Jimenez quickly authorized a one-year, . This was considerably more than Novartis Washington lobbyists. And it wasn’t for Cohen’s policy expertise — he knew nothing about health care.
